Memed
5 known investors
Find your way into Memed
MeMed develops a rapid 15-minute diagnostic test using machine learning to distinguish bacterial from viral infections by analyzing immune system biomarkers. The test serves physicians and hospitals to reduce inappropriate antibiotic prescriptions and improve patient outcomes in acute infection management.
Investors · 5
Qualcomm VenturesSan Diego · $5M
Bridge Onereported · 2 sources
DGFreported · 2 sourcesSão Paulo
DNA Capitalreported · 2 sourcesSão Paulo · $100K – $5M
Also in the syndicate · 1
BridgeOnelead
In the news
Frequently asked questions
- What does Memed do?
- MeMed develops a rapid 15-minute diagnostic test using machine learning to distinguish bacterial from viral infections by analyzing immune system biomarkers. The test serves physicians and hospitals to reduce inappropriate antibiotic prescriptions and improve patient outcomes in acute infection management.
- Who are Memed's investors?
- Memed's investors include Qualcomm Ventures, Bridge One, DGF, DNA Capital.